Annual Retained Earnings
-$197.78 M
-$39.48 M-24.94%
December 31, 2023
Summary
- As of February 7, 2025, ONCT annual retained earnings is -$197.78 million, with the most recent change of -$39.48 million (-24.94%) on December 31, 2023.
- During the last 3 years, ONCT annual retained earnings has fallen by -$114.98 million (-138.87%).
- ONCT annual retained earnings is now -20740.78% below its all-time high of -$949.00 thousand, reached on December 31, 1999.
Performance
ONCT Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$223.19 M
-$8.46 M-3.94%
September 30, 2024
Summary
- As of February 7, 2025, ONCT quarterly retained earnings is -$223.19 million, with the most recent change of -$8.46 million (-3.94%) on September 30, 2024.
- Over the past year, ONCT quarterly retained earnings has dropped by -$17.02 million (-8.26%).
- ONCT quarterly retained earnings is now -294.86% below its all-time high of -$56.52 million, reached on June 30, 2019.
Performance
ONCT Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
ONCT Retained Earnings Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -24.9% | -8.3% |
| 3 y3 years | -138.9% | -31.4% |
| 5 y5 years | +67.0% | -31.4% |
ONCT Retained Earnings Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -73.3% | at low | -95.6% | at low |
| 5 y | 5-year | -201.6% | at low | -240.4% | at low |
| alltime | all time | <-9999.0% | +67.0% | -294.9% | +63.2% |
Oncternal Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -$223.19 M(+3.9%) |
| Jun 2024 | - | -$214.73 M(+4.2%) |
| Mar 2024 | - | -$206.17 M(+4.2%) |
| Dec 2023 | -$197.78 M(+24.9%) | -$197.78 M(+4.9%) |
| Sep 2023 | - | -$188.62 M(+5.5%) |
| Jun 2023 | - | -$178.75 M(+5.3%) |
| Mar 2023 | - | -$169.79 M(+7.3%) |
| Dec 2022 | -$158.30 M(+38.7%) | -$158.30 M(+7.8%) |
| Sep 2022 | - | -$146.90 M(+8.2%) |
| Jun 2022 | - | -$135.78 M(+9.5%) |
| Mar 2022 | - | -$124.03 M(+8.7%) |
| Dec 2021 | -$114.13 M(+37.8%) | -$114.13 M(+7.6%) |
| Sep 2021 | - | -$106.06 M(+10.0%) |
| Jun 2021 | - | -$96.43 M(+8.7%) |
| Mar 2021 | - | -$88.75 M(+7.2%) |
| Dec 2020 | -$82.80 M(+26.3%) | -$82.80 M(+3.2%) |
| Sep 2020 | - | -$80.24 M(+5.8%) |
| Jun 2020 | - | -$75.84 M(+7.9%) |
| Mar 2020 | - | -$70.31 M(+7.2%) |
| Dec 2019 | -$65.57 M(-89.1%) | -$65.57 M(+6.8%) |
| Sep 2019 | - | -$61.42 M(+8.7%) |
| Jun 2019 | - | -$56.52 M(-90.7%) |
| Mar 2019 | - | -$605.86 M(+1.0%) |
| Dec 2018 | -$600.05 M(+6.8%) | -$600.05 M(+0.9%) |
| Sep 2018 | - | -$594.64 M(+1.6%) |
| Jun 2018 | - | -$585.21 M(+1.7%) |
| Mar 2018 | - | -$575.19 M(+2.4%) |
| Dec 2017 | -$561.64 M(+5.7%) | -$561.64 M(+1.7%) |
| Sep 2017 | - | -$552.36 M(+1.6%) |
| Jun 2017 | - | -$543.86 M(+1.2%) |
| Mar 2017 | - | -$537.45 M(+1.2%) |
| Dec 2016 | -$531.20 M(+3.5%) | -$531.20 M(+1.3%) |
| Sep 2016 | - | -$524.33 M(+1.3%) |
| Jun 2016 | - | -$517.42 M(+1.2%) |
| Mar 2016 | - | -$511.37 M(-0.4%) |
| Dec 2015 | -$513.47 M(+3.8%) | -$513.47 M(+0.6%) |
| Sep 2015 | - | -$510.24 M(-6.4%) |
| Jun 2015 | - | -$545.11 M(+9.6%) |
| Mar 2015 | - | -$497.15 M(+0.5%) |
| Dec 2014 | -$494.77 M(+8.7%) | -$494.77 M(+3.0%) |
| Sep 2014 | - | -$480.23 M(+1.0%) |
| Jun 2014 | - | -$475.29 M(+2.4%) |
| Mar 2014 | - | -$464.35 M(+2.0%) |
| Dec 2013 | -$455.36 M | -$455.36 M(+1.7%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2013 | - | -$447.57 M(+2.0%) |
| Jun 2013 | - | -$438.63 M(+3.0%) |
| Mar 2013 | - | -$425.83 M(+3.0%) |
| Dec 2012 | -$413.25 M(+7.0%) | -$413.25 M(+3.3%) |
| Sep 2012 | - | -$400.23 M(-1.8%) |
| Jun 2012 | - | -$407.63 M(+2.6%) |
| Mar 2012 | - | -$397.25 M(+2.9%) |
| Dec 2011 | -$386.17 M(+9.4%) | -$386.17 M(+2.8%) |
| Sep 2011 | - | -$375.49 M(+2.6%) |
| Jun 2011 | - | -$366.15 M(+3.0%) |
| Mar 2011 | - | -$355.48 M(+0.7%) |
| Dec 2010 | -$352.88 M(-4.2%) | -$352.88 M(+2.2%) |
| Sep 2010 | - | -$345.35 M(+2.5%) |
| Jun 2010 | - | -$336.78 M(+4.0%) |
| Mar 2010 | - | -$323.83 M(-12.0%) |
| Dec 2009 | -$368.17 M(+14.4%) | -$368.17 M(+3.0%) |
| Sep 2009 | - | -$357.30 M(+3.7%) |
| Jun 2009 | - | -$344.48 M(+3.4%) |
| Mar 2009 | - | -$333.22 M(+3.5%) |
| Dec 2008 | -$321.92 M(+19.2%) | -$321.92 M(+4.5%) |
| Sep 2008 | - | -$308.05 M(+4.0%) |
| Jun 2008 | - | -$296.12 M(+4.7%) |
| Mar 2008 | - | -$282.88 M(+4.7%) |
| Dec 2007 | -$270.14 M(+17.6%) | -$270.14 M(+5.0%) |
| Sep 2007 | - | -$257.35 M(+4.1%) |
| Jun 2007 | - | -$247.11 M(+3.9%) |
| Mar 2007 | - | -$237.90 M(+3.5%) |
| Dec 2006 | -$229.78 M(+18.3%) | -$229.78 M(+2.1%) |
| Sep 2006 | - | -$225.07 M(+5.1%) |
| Jun 2006 | - | -$214.18 M(+4.9%) |
| Mar 2006 | - | -$204.19 M(+5.1%) |
| Dec 2005 | -$194.27 M(+23.4%) | -$194.27 M(+4.2%) |
| Sep 2005 | - | -$186.47 M(+5.6%) |
| Jun 2005 | - | -$176.53 M(+6.0%) |
| Mar 2005 | - | -$166.51 M(+5.8%) |
| Dec 2004 | -$157.43 M(+3.7%) | -$157.43 M(+4.6%) |
| Sep 2004 | - | -$150.55 M(+3.5%) |
| Jun 2004 | - | -$145.42 M(+3.2%) |
| Mar 2004 | - | -$140.90 M(-7.1%) |
| Dec 2003 | -$151.75 M(+169.6%) | -$151.75 M |
| Dec 2002 | -$56.28 M(+60.6%) | - |
| Dec 2001 | -$35.05 M(+34.1%) | - |
| Dec 2000 | -$26.14 M(+2654.0%) | - |
| Dec 1999 | -$949.00 K | - |
FAQ
- What is Oncternal Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Oncternal Therapeutics?
- What is Oncternal Therapeutics annual retained earnings year-on-year change?
- What is Oncternal Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Oncternal Therapeutics?
- What is Oncternal Therapeutics quarterly retained earnings year-on-year change?
What is Oncternal Therapeutics annual retained earnings?
The current annual retained earnings of ONCT is -$197.78 M
What is the all time high annual retained earnings for Oncternal Therapeutics?
Oncternal Therapeutics all-time high annual retained earnings is -$949.00 K
What is Oncternal Therapeutics annual retained earnings year-on-year change?
Over the past year, ONCT annual retained earnings has changed by -$39.48 M (-24.94%)
What is Oncternal Therapeutics quarterly retained earnings?
The current quarterly retained earnings of ONCT is -$223.19 M
What is the all time high quarterly retained earnings for Oncternal Therapeutics?
Oncternal Therapeutics all-time high quarterly retained earnings is -$56.52 M
What is Oncternal Therapeutics quarterly retained earnings year-on-year change?
Over the past year, ONCT quarterly retained earnings has changed by -$17.02 M (-8.26%)